Entities affiliated with Paul R. Vigano, recognized as a ten percent owner in Aveanna Healthcare Holdings, Inc. (NASDAQ:AVAH), collectively liquidated a significant block of 1,000,000 common shares on June 24, 2026. The total value realized from this divestment reached $8,000,000, with all shares transacted at a uniform price of $8.00 per share.
The transaction structure involved three separate entities, with Mr. Vigano occupying various managing member and senior managing director roles. These positions grant him potential voting and dispositive power over the shares, though he formally disclaims beneficial ownership except for his direct pecuniary interest. The stock currently trades at $8.55, placing it slightly above the execution price of the sale. Over the preceding year, the equity has delivered a 76% return, though InvestingPro data highlights considerable volatility in price movements, a factor investors must weigh when interpreting this insider activity.
The liquidation was executed across three specific vehicles. J.H. Whitney VII, L.P. disposed of 919,389 shares, leaving it with an indirect holding of 12,531,158 shares post-transaction. JHW Iliad Holdings LLC reduced its position by 72,963 shares, retaining an indirect stake of 2,339,639 shares. A third entity, JHW Iliad Holdings II LLC, sold 7,648 shares, maintaining an indirect holding of 245,251 shares. Beyond these specific sales, entities linked to Mr. Vigano maintain substantial indirect holdings, including 15,523,810 shares held by PSA Healthcare Investment Holdings LLC and 1,426,034 shares held by PSA Iliad Holdings LLC. Mr. Vigano holds no direct shares.
Despite the insider sale, InvestingPro analysis suggests the stock remains undervalued relative to its Fair Value assessment. For comprehensive insights, investors may access a Pro Research Report on AVAH, which is part of a broader coverage of 1,400+ US equities featuring expert analysis and actionable intelligence.
Concurrently, Aveanna Healthcare has advanced significant corporate and financial developments. The company recently completed its acquisition of Family First Holding, LLC for $175.5 million in cash. This transaction expands Aveanna’s platform through Family First Homecare, which operates 27 locations across seven states, delivering skilled Private Duty Nursing services.
Financially, Moody’s Ratings upgraded Aveanna Healthcare’s corporate family rating to B2 from B3. The upgrade cites improved business performance and reduced leverage, reflecting strategic initiatives that have driven business volume growth and lowered operating costs. Additionally, Aveanna Healthcare repriced its first lien credit facility and revolving credit facility, reducing interest rate margins by 50 basis points. The terms allow for a potential additional 25 basis point reduction if specific credit ratings are achieved.
Market sentiment has also shifted positively, with RBC Capital upgrading Aveanna Healthcare’s stock rating to Outperform from Sector Perform. The firm set a price target of $10.00, attributing the upgrade to solid execution on preferred payor relationships and the expanded platform scale from the recent acquisition. These developments indicate substantial strategic and financial changes for the company.